Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The most common treatment for hair loss in the study was a 5% minoxidil solution, with women more likely to receive multiple medications. A significant number of patients also had hypothyroidism.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Acne is linked to complex skin microbe interactions, and new findings suggest microbiome-based treatments could be effective.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

Cannabinoids may help treat various skin conditions.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

New treatments for PCOS show promise, including both medication and non-medication options.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Shift work disrupts the body's natural clock, leading to health problems.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Inhibiting ODC can prevent UV-induced skin cancer.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Children with darker skin tones can have specific skin conditions that need tailored treatments.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Women with female pattern hair loss have lower Vitamin D3 levels.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.